In the context of cancer, FABP4 is crucial in driving tumour proliferation, metastasis, and drug resistance by activating oncogenic signalling pathways and modulating cellular metabolism to meet energy demands, highlighting its potential as a therapeutic target in cancer treatment [99]. This evidence concerns the gene FABP4 and cancer.